Prenatal diagnosis and heterozygote detection by DNA analysis in ornithine transcarbamylase deficiency.
This report summarizes our experience with DNA analysis using a complementary DNA probe for ornithine transcarbamylase in 24 individuals or families with deficiency of this enzyme. In four cases, including three reported elsewhere, a Taql restriction site alteration directly detected the mutation. In 10 additional cases, only an affected male was available, and results of DNA analysis using the Taql enzyme were normal. In 10 cases, family studies were performed with the use of restriction fragment length polymorphisms. Prenatal diagnostic studies were performed for three informative pregnancies, and two affected male fetuses were identified. Analysis of two restriction fragment length polymorphisms, Mspla and BamHl, was informative in 14 of 19 (74%) known carrier females and in 21 of 35 (60%) females (the total number studied). One female previously predicted to be a noncarrier by protein-loading test was determined to be a carrier by analysis of restriction fragment length polymorphisms. The frequency of Taql site alterations was 4 of 24 families (17%). These data illustrate the importance of DNA analysis, pedigree analysis, and biochemical testing in families with ornithine transcarbamylase deficiency to detect carriers and establish the diagnosis prenatally.
Spence
J E
JE
Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Maddalena
A
A
O'Brien
W E
WE
Fernbach
S D
SD
Batshaw
M L
ML
Leonard
C O
CO
Beaudet
A L
AL
D015139:Blotting, Southern; D004247:DNA / Q000032:analysis; D005260:Female; D006580:Genetic Carrier Screening; D006801:Humans; D008297:Male; D020163:Ornithine Carbamoyltransferase Deficiency Disease; D010375:Pedigree; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D011296:Prenatal Diagnosis
D004247:DNA